Timing Pharmaceutical Co

Timing Pharmaceutical Co EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Timing Pharmaceutical Co (6659.TWO) as of Nov 3, 2026 is 18.60. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 12.62 — a change of 47.41% (higher).

EV/OCF

18.60

YoY

47.41%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Timing Pharmaceutical Co is 2024 18.60 . EV/OCF (Enterprise Value to Operating Cash Flow) of Timing Pharmaceutical Co was 2023 12.62 . It decreases by 47.41% higher compared to the previous year.

The Timing Pharmaceutical Co EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2022
16.29 TWD
Jan 1, 2023
12.62 TWD
Jan 1, 2024
18.60 TWD
The Timing Pharmaceutical Co EV/OCF history
YEAREV/OCFYoY
18.60+47.41%
12.62-22.54%
16.29—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Timing Pharmaceutical Co Stock analysis

What does Timing Pharmaceutical Co do? Timing Pharmaceutical Co Ltd generates revenue through manufacturing concentrated Chinese medicine preparations, health foods, and traditional Chinese medicine formulations for domestic and overseas markets. The company accepts applications for licenses and permits related to Chinese medicine, food, and pharmaceutical products, and offers contract manufacturing services. Its comprehensive sales network covers Chinese medicine hospitals and major pharmacies across Taiwan, supported by a professional supply chain and service network. The firm also provides testing services and CDMO services for new pilot projects in research and development. The primary buyers of Timing Pharmaceutical's products include Chinese medicine hospitals, major pharmacies, and overseas markets. Domestic sales are facilitated through a full-fledged professional supply chain and service network, while overseas markets are served through direct exports and partnerships. The company's focus on traditional Chinese medicine and pharmaceuticals drives demand from healthcare institutions and consumers seeking natural health solutions. Timing Pharmaceutical Co Ltd invests annually in research and development for new pilot projects, which are supported by its contract research and development and manufacturing organization (CDMO) services. These services are contracted by clients seeking to develop and manufacture pharmaceutical products, including traditional Chinese medicine formulations. The company's portfolio includes concentrated Chinese medicine preparations, health foods, and traditional Chinese medicine formulations, all of which are distributed through its established network. Timing Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Timing Pharmaceutical Co stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Timing Pharmaceutical Co is 18.60 in 2024.

EV/OCF (Enterprise Value to Operating Cash Flow) of Timing Pharmaceutical Co changed from 12.62 to 18.60, representing a 47.41% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Timing Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Timing Pharmaceutical Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Timing Pharmaceutical Co

All Key Metrics — Timing Pharmaceutical Co